Kearney Terrence C 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 3, 2023
Insider Transaction Report
Form 4
Kearney Terrence C
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-01+3,481→ 3,481 totalExercise: $342.73Exp: 2033-04-30→ Common Stock (3,481 underlying)
Footnotes (1)
- [F1]Fully vested.